{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.0",
    "document_metadata": {
      "copyright": "Copyright Â© 2018 Fraunhofer Institute SCAI, All rights reserved",
      "licenses": "CC BY 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "name": "In Vivo and In Vitro Characterization of Antalarmin, a Nonpeptide Corticotropin-Releasing Hormone (CRH) Receptor Antagonist: Suppression of Pituitary ACTH Release and Peripheral Inflammation",
      "version": "1.0.0",
      "authors": "Kristian Kolpeja",
      "description": ""
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "CL": "^\\d{7}$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_list": {
      "AssayType": [
        "B"
      ],
      "MeasurementType": [
        "Ki"
      ],
      "MeasurementUnits": [
        "nM"
      ],
      "MeasurementRelation": [
        "="
      ],
      "MeasurementValue": [
        "1.3",
        "1.4",
        "1.9"
      ]
    },
    "path": "/Users/cthoyt/dev/knowledge/hbp_knowledge/lewis1996.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "antalarmin",
      "id": "28e79e7132b24ce51158bb2dc3f9f390011d94eeeb2f659bebb29ae2402a97fea0953d1185cb0551e0d9c243579ecda82a908b0b00073d050e4a28ca647c05ce"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "inflammatory response",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900"
    },
    {
      "function": "Protein",
      "namespace": "RGD",
      "name": "Crh",
      "id": "3f843a4cf4dc22cef31ce5ee461be73605c83880dc97a543da609e77d24862368f5a5d31719d535467e386ad8e40e17ca0c355b8ab9bea90a22e29d16d41f58e"
    },
    {
      "function": "Protein",
      "namespace": "RGD",
      "name": "Crhr1",
      "id": "5fda058086d8734f622658f82b9bae354a376917eeee1f979cbb6929d7e135b5a4d3c26da72495d13775cf14bdc48347d6e55e2463554ba6541508e7d9981fa9"
    },
    {
      "function": "Protein",
      "namespace": "RGD",
      "name": "Pomc",
      "id": "d257157819e1bc033beeefdb183bc15f0ddfd4378f631158a4388b8ff59c3aaadb3c5a2d05af1026d2587a1849f30bb3cacbcde20d17fc3afc218804d1ca06ba"
    }
  ],
  "links": [
    {
      "line": 80,
      "relation": "positiveCorrelation",
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "citation": {
        "type": "PubMed",
        "reference": "8940412"
      },
      "annotations": {
        "Species": {
          "10116": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 2,
      "target": 1,
      "key": "530e2b124518f599ab9adfcbfec36061805a001cc49a77bbac352a410d2df3d25665d1306aff075c24dce3797ce2be55552804c2497073a3cbebe2d8f2e5c24c"
    },
    {
      "line": 81,
      "relation": "regulates",
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "citation": {
        "type": "PubMed",
        "reference": "8940412"
      },
      "annotations": {
        "Species": {
          "10116": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 2,
      "target": 4,
      "key": "b1aeb54e0f12605e8b9273eb808b0399bc93a26905ea1d063abe8c442486ae44c97edc5c3056c88fda6ddfffe97306d7ea46f26a0cc2ef6ad821b17bd5a5fee9"
    },
    {
      "line": 93,
      "relation": "directlyIncreases",
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "citation": {
        "type": "PubMed",
        "reference": "8940412"
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "AssayType": {
          "B": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "Anatomy": {
          "pituitary gland": true
        },
        "MeasurementValue": {
          "1.9": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 2,
      "target": 3,
      "key": "40a04dbabe438b8b8fafdfdc7bd04708f737b6736872da95889695d708e494d3cfc3126236b9304b4a8d0a9762dd91fc6ae16addbcbc4b19e65753f46ca79cb1"
    },
    {
      "line": 80,
      "relation": "positiveCorrelation",
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "citation": {
        "type": "PubMed",
        "reference": "8940412"
      },
      "annotations": {
        "Species": {
          "10116": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 1,
      "target": 2,
      "key": "0dcc3379615f5232a3fba98e915705dee2430979d68309bf900dc1e0a32fb0760202258b17b3d8fa37fec9eb563c5163707e3bef2b6aad3c4576675f26f3575e"
    },
    {
      "line": 120,
      "relation": "negativeCorrelation",
      "evidence": "These results raise the possibility that pyrrolopyrimidine compounds, such as antalarmin, which antagonize CRH at the level of its own receptor, have therapeutic potential in some forms of inflammation.",
      "citation": {
        "type": "PubMed",
        "reference": "8940412"
      },
      "annotations": {
        "Species": {
          "10116": true
        }
      },
      "source": 1,
      "target": 0,
      "key": "e4b30e052332aa2e3a46c7499d492da0ea5606dbeb371da05994d7ee0160bd3a7c1df587500016b50ad7c7741053141c026969986cf73f62c0017c5e785406a3"
    },
    {
      "line": 92,
      "relation": "directlyDecreases",
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "citation": {
        "type": "PubMed",
        "reference": "8940412"
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "AssayType": {
          "B": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "Anatomy": {
          "pituitary gland": true
        },
        "MeasurementValue": {
          "1.9": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 0,
      "target": 2,
      "key": "1d22d26c4f1fff94b2cf854e6398ca4615577c51747a04939e8fdec58ea987cf7fdbb028bfe3bc3268872d27e8d7f6a1772a598ad29992755114b358cd572cc8"
    },
    {
      "line": 94,
      "relation": "directlyDecreases",
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "citation": {
        "type": "PubMed",
        "reference": "8940412"
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "AssayType": {
          "B": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "Anatomy": {
          "pituitary gland": true
        },
        "MeasurementValue": {
          "1.9": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 0,
      "target": 3,
      "key": "3f8dfcae335a7949fe86a4766cc69ba2dda3f8fc6fc0462731d2a07f69cb3bb41255bb00584cb62d1337b8e5003b350d01ee7cbf0f3d9a8d683922c35d776e7c"
    },
    {
      "line": 120,
      "relation": "negativeCorrelation",
      "evidence": "These results raise the possibility that pyrrolopyrimidine compounds, such as antalarmin, which antagonize CRH at the level of its own receptor, have therapeutic potential in some forms of inflammation.",
      "citation": {
        "type": "PubMed",
        "reference": "8940412"
      },
      "annotations": {
        "Species": {
          "10116": true
        }
      },
      "source": 0,
      "target": 1,
      "key": "8bd32354bc87fa37ddeed0483100685d15a9543f75ef82c7a915e54c3d868407a05d94a7a1909ea76810e6822dc382a677c87725e0df0fd59da319ed59aaaa28"
    },
    {
      "line": 125,
      "relation": "decreases",
      "evidence": "Indeed, the compound significantly suppressed (XI-l-induced ACTH secretion to approximately the same extent as neutralizing polyclonal anti-CRH.",
      "citation": {
        "type": "PubMed",
        "reference": "8940412"
      },
      "annotations": {
        "Species": {
          "10116": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 0,
      "target": 4,
      "key": "ff1e6fd88bdbd069aeff0bf05d4a340f36a36ce04cc6aeef0d1046e0cc57ee07dccb7ee9484f36ae6391fac39d9887082ae4f3c4ead3849d0007f68a47bb9cdf"
    }
  ]
}